glimepiride has been researched along with Heart Disease, Ischemic in 6 studies
glimepiride: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " Myocardial ischemia after coronary angioplasty was evaluated in 20 nondiabetic and 23 diabetic patients chronically taking either glibenclamide or glimepiride." | 3.72 | Impairment of myocardial protection in type 2 diabetic patients. ( Chou, TF; Lee, TM, 2003) |
| "Glimepiride (Glim) is a new sulfonylurea reported to affect nonpancreatic K(ATP) channels less than does Glib." | 1.31 | Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. ( Baxter, GF; Lawrence, CL; Maddock, HL; Mocanu, MM; Standen, NB; Yellon, DM, 2001) |
| "Glimepiride is a new sulfonylurea." | 1.29 | Cardiovascular effects of conventional sulfonylureas and glimepiride. ( Geisen, K; Krause, E; Papp, JG; Végh, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, S | 1 |
| Ayabe, S | 1 |
| Sekine, N | 1 |
| Ye, Y | 1 |
| Lin, Y | 1 |
| Perez-Polo, JR | 1 |
| Birnbaum, Y | 1 |
| Lee, TM | 1 |
| Chou, TF | 1 |
| Geisen, K | 1 |
| Végh, A | 1 |
| Krause, E | 1 |
| Papp, JG | 2 |
| Bozdogan, O | 1 |
| Leprán, I | 1 |
| Mocanu, MM | 1 |
| Maddock, HL | 1 |
| Baxter, GF | 1 |
| Lawrence, CL | 1 |
| Standen, NB | 1 |
| Yellon, DM | 1 |
1 review available for glimepiride and Heart Disease, Ischemic
| Article | Year |
|---|---|
Myocardial Injury without Electrocardiographic Changes after a Suicide Attempt by an Overdose of Glimepiride and Zolpidem: A Case Report and Literature Review.
Topics: Adult; Biomarkers; Creatine Kinase, MB Form; Drug Overdose; GABA-A Receptor Agonists; Heart Injuries | 2015 |
5 other studies available for glimepiride and Heart Disease, Ischemic
| Article | Year |
|---|---|
Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
Topics: Administration, Oral; Animals; Body Weight; Coronary Vessels; Data Interpretation, Statistical; Deca | 2008 |
Impairment of myocardial protection in type 2 diabetic patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Chest Pain; Diabetes Mellitus, Type 2; Electro | 2003 |
Cardiovascular effects of conventional sulfonylureas and glimepiride.
Topics: Animals; Blood Pressure; Cardiovascular System; Coronary Vessels; Diabetes Mellitus, Experimental; D | 1996 |
Effect of glimepiride and glibenclamide, inhibitors of ATP-dependent K(+)-channel, on ischaemia-reperfusion induced arrhythmias in rats.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Glyburide; | 1996 |
Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
Topics: Animals; Diazoxide; Glyburide; Guanosine Triphosphate; Heart; Heart Ventricles; Hemodynamics; Hypogl | 2001 |